Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern
Recommend:
0

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
Recommend :
0
React to this article
Latest news
Date Title
<1m ago DHL Launches New Logistics Service for Life Sciences Products Handled at Extremely Low Temperatures
1m ago PHOTOMEDEX : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K/A)
1m ago PETRO ONE ENERGY : Announces Drilling Joint Venture
2m ago ENEL GREEN POWER : breaks ground on its first wind farm in Uruguay
2m ago INGRAM MICRO : Hosts Inaugural Women of Technology Event
3m ago TEXTRON : Cessna upgrades TTx with new Surge package, McCauley propeller
3m ago TEXTRON : Beechcraft celebrates King Air milestones at EAA AirVenture Oshkosh
3m ago TEXTRON : Cessna product launch reinforces commitment to diesel fuel
3m ago TEXTRON : Aviation debuts at EAA AirVenture Oshkosh
3m ago CLOSE BROTHERS : Additional Listing
Latest news
Advertisement
Hot News 
STADIUM : Buys United Wireless For Up To GBP8 Million Cash And Shares
EL POLLO LOCO : Prices Its Initial Public Offering
FAMILY DOLLAR STORES : Dollar Tree, Inc. : to Acquire Family Dollar Stores, Inc. to Create North America’s Leading Discount Retailer
ARMSTRONG WORLD : Reports Second Quarter 2014 Results
FLOWGROUP : Director/PDMR Shareholding
Most Read News
1d ago WAL MART STORES : Man Charged With Arson In Fire At Stevens Church
1d ago NORFOLK SOUTHERN : Columbia Street Closing For Repairs
1d ago MOODY : Blues ; Guiding Pennsylvania Out Of The Recession And Its Consequences, As Well As The Gathering Storm Of Pension Payments, Requires Creative...
14h ago QUESTERRE ENERGY : updates Montney activities
4h ago Hague court orders Russia to pay over $50 billion in Yukos case
Most recommended articles
3m ago MACQUARIE : Ontario Teachers says plans to increase stake in UK's Bristol Airport
6m ago Tyson to sell Mexico, Brazil poultry businesses to JBS
17m ago ROSNEFT' NK : Russia to challenge Hague Court's Yukos ruling - Finance Ministry
20m agoDJBOND REPORT : Treasury Sells 2-year Notes At Highest Yield Since 2011
23m ago EXCLUSIVE - CVC IN LEAD TO BUY EPICOR FOR MORE THAN $3 BILLION : sources
Dynamic quotes  
ON
| OFF